XORTX Therapeutics Inc share price logo

XORTX Therapeutics Inc

NASDAQ: XRTX

$1.92

+0.26

(+15.66%)

as on

XORTX Therapeutics Inc Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.74
    $2.65
    downward going graph

    9.37%

    Downside

    38.02%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.59
    $7.05
    downward going graph

    17.18%

    Downside

    267.19%

    Upside

    downward going graph

XORTX Therapeutics Inc share price movements today

Previous Close
$1.66
Open
$1.94
Volume
7.1M
Market Cap
$4.2M
Day's Low - High
$1.74 - $2.65
52 Week Low - High
$1.59 - $7.05

XORTX Therapeutics Inc Historical Returns

1 Month Return
-17 %
3 Month Return
-20.57 %
1 Year Return
-60.04 %
3 Year Return
-94.21 %
5 Year Return
0 %

XORTX Therapeutics Inc Stock Fundamentals & Key Indicators

Check XORTX Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.2M

EPS (TTM)

-7.21

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.32

Industry PE ratio

-2.37

PEG Ratio

-0.008156427354221028

EBITDA

-2.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-126.96%

XORTX Therapeutics Inc Stock Valuation

Track how XORTX Therapeutics Inc P/E has moved over time to understand its valuation trends.

XORTX Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-14.90x)

March 31, 2022

Industry (-2.37x)

December 31, 2025

Today (-1.36x)

December 31, 2025

Highest (-1.36x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.36x

XORTX Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of XORTX Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
XORTX Therapeutics Inc image
XORTX Therapeutics Inc
BUY$4.2MNA-0.320.00%0.00%
Moderna image
Moderna
BUY$63.1B-63.24%-19.81-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$130.1B174.21%29.8186.04%0.00%
Regeneron image
Regeneron
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for XORTX Therapeutics Inc Stock including INR - Dollar returns

The XORTX Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

XORTX Therapeutics Inc investment value today

Current value as on today

₹50,302

Returns

-₹49,698

(-49.7%)

Returns from XORTX Therapeutics Inc Stock

-₹53,779 (-53.78%)

Dollar Impact

₹4,082 (+4.08%)

Analyst Recommendation on XORTX Therapeutics Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for XORTX Therapeutics Inc. Average target price of $14.04

XORTX Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on XORTX Therapeutics Inc.

What analysts predicted

86.32%UPSIDE

Target Price

$14.04

Current Price

$1.92

Analyzed by

5 Analysts

Target

$14.04

XORTX Therapeutics Inc target price $14.04, a slight upside of 86.32% compared to current price of $1.92. According to 5 analysts rating.

Indian Investors' Interest in XORTX Therapeutics Inc Stock

Search interest for XORTX Therapeutics Inc Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:58% versus previous 30 day period

XORTX Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
0
0
0
0
0
Operating Income
-1
-3
0
0
0
0
0
0
0
-1
EBITDA
-1
-1
0
0
0
0
0
0
-
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
0
0
0
0
0
0
0
0
-1
Income Tax Expense
1
-
-
-
-
-
-
-
-
-
Net Income
-3
0
0
0
0
0
0
0
0
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

XORTX Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
Operating Income
0
-1
0
-1
-2
-12
-6
-3
EBITDA
0
-1
0
-1
-2
-9
-6
-3
Interest Expense
0
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
0
-3
0
-1
-1
-9
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
0
-3
0
-1
-1
-6
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

XORTX Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
0
0
0
0
0
0
0
0
-1
Operating Cash Flow
-1
0
0
0
0
0
0
0
0
-3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
1
0
0
1
0
0
0
0
0
4
Change in Cash
0
0
0
0
0
0
0
0
0
0

XORTX Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Dec 2024
Dec 2025
Net Income
0
-3
0
-1
-1
-7
-2
-3
-2
Operating Cash Flow
0
0
0
0
-4
-8
-6
-3
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
1
0
0
19
6
0
2
1
Change in Cash
0
0
0
1
14
-4
-6
0
-1

Global Institutional Holdings in XORTX Therapeutics Inc

Funds
Holdings
Armistice Capital, LLC
0%
Citadel Advisors Llc
1.27%
Advisor Group Holdings, Inc.
0%
Kingsview Wealth Management, LLC
0.83%
NATIONAL BANK OF CANADA /FI/
0%
See all

XORTX Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 28 August

    Fri, 04:30 PM

    -

    Xortx Therapeutics terminates investor relations agreement and postpones marketing program amid voluntary delisting from TSX Venture Exchange.

Insights on XORTX Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 137.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 564.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, XRTX stock has moved down by -17.6%

About XORTX Therapeutics Inc

Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
OrganisationXORTX Therapeutics Inc
Headquarters3710 - 33rd Street NW, Calgary, AB, T2L 2M1, CA
IndustryBiotechnology
CEOAllen Warren Davidoff
E-voting on sharesClick here to vote

Key Management of XORTX Therapeutics Inc

Name

Title

Mr. Mika Grasso

Co-CEO & Director

Dr. David Sans M.B.A., Ph.D.

Director of Corporate Development

Dr. Michael Scott Bumby D.V.M., M.B.A.

Chief Financial Officer

Dr. Stacy Evans M.B.A., M.D.

Chief Business Officer

Nick Rigopulos

Director of Communications

Dr. David MacDonald Ph.D.

Consultant of Clinical Operations

Ms. Charlotte May

Corporate Secretary

Dr. Allen Warren Davidoff Ph.D.

Founder, Co-CEO, President & Director

Dr. Stephen Haworth M.D., MRCP

Chief Medical Officer

FAQs

What is XORTX Therapeutics Inc share price today?

XORTX Therapeutics Inc share price today is $1.92 as on at the close of the market. XORTX Therapeutics Inc share today touched a day high of $2.65 and a low of $1.74.

What is the 52 week high and 52 week low for XORTX Therapeutics Inc share?

XORTX Therapeutics Inc share touched a 52 week high of $7.05 on and a 52 week low of $1.59 on . XORTX Therapeutics Inc stock price today i.e. is closed at $1.92,which is 72.77% down from its 52 week high and 20.75% up from its 52 week low.

What is XORTX Therapeutics Inc's market capitalisation today?

XORTX Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in XORTX Therapeutics Inc Stock (XRTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for XORTX Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in XORTX Therapeutics Inc Shares that will get you 0.7813 shares as per XORTX Therapeutics Inc share price of $1.92 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy XORTX Therapeutics Inc Stock (XRTX) from India?

Indian investors can start investing in XORTX Therapeutics Inc (XRTX) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in XORTX Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on XORTX Therapeutics Inc share’s latest price of $1.92 as on September 19, 2026 at 8:45 am IST, you will get 5.2083 shares of XORTX Therapeutics Inc. Learn more about fractional shares .